REVERSE TRIIODOTHYRONINE (T3) - ANVISA Registration 10338930243

Access comprehensive regulatory information for REVERSE TRIIODOTHYRONINE (T3) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930243 and manufactured by EUROIMMUN AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., WUHAN HUAMEI BIOTECH CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10338930243
2 Related Devices
Registration Details
ANVISA Registration Number: 10338930243
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10338930243

25351467560202043

93741726000166

Company Information

EUROIMMUN AG
Germany
PT: ALEMANHA

Dates and Status

Dec 10, 2020

VIGENTE

09/18/2025 19:00:01

Registration Details

10338930243

25351467560202043

93741726000166

Company Information

Brazil
PT: BRASIL

Dates and Status

Dec 10, 2020

VIGENTE

09/18/2025 19:00:01